Robert Allen
Chief Tech/Sci/R&D Officer at INVIVYD, INC.
Net worth: - $ as of 2024-04-29
Profile
Robert D.
Allen is currently the Chief Scientific Officer at Invivyd, Inc. He previously worked as the Scientific Director at Oregon Translational Research & Development Institute and as the Senior Vice President-Research & Development at Sorrento Therapeutics, Inc. From 2020 to 2023, he served as the Chief Scientific Officer at SmartPharm Therapeutics, Inc. Dr. Allen holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Georgia Institute of Technology, and an undergraduate degree from Rhodes College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 2024-03-21 | 0 ( -.--% ) | - $ | 2024-04-29 |
Robert Allen active positions
| Companies | Position | Start |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 2023-04-11 |
Former positions of Robert Allen
| Companies | Position | End |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| Oregon Translational Research & Development Institute | Chief Tech/Sci/R&D Officer | - |
| SORRENTO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Robert Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Robert Allen